6
SQBI0206.TXT

SQBI
Squibb Indonesia Tbk (Preferred Stocks)
Af          :
Sector Code : 53
Sector Name : PHARMACEUTICALS

(In thousand rupiah except Par Value, Closing Price and Ratios)

Financial Statement Date    : 30-Jun-2002
Fiscal Year Ends            : Dec
Months Covered in Income St : 6

Summary of Balance Sheet
  Receivables               :      39,930,481.00
  Inventories               :      32,889,857.00
  Current Assets            :     115,649,270.00
  Fixed Assets              :      33,469,264.00
  Other Asstes              :               0.00
  Total Assets              :     155,382,373.00
  Current Liabilities       :      69,242,393.00
  Longterm Liabiities       :       5,769,816.00
  Total Liabilities         :      75,012,209.00
  Authorized                :             972.00
  Paid-up Capital           :         972,000.00
  Par Value                 :               1000
  Paid-up Capital Shares    :             972.00
  Retained Earnings         :      -6,905,836.00
  Total Equity              :      80,370,164.00
  Minority Interest         :               0.00

Summary of Income Statement
  Total Sales               :     144,790,056.00
  Cost of Good Sold         :      96,764,903.00
  Gross Profit              :      48,025,153.00
  Operating Profit          :      17,281,437.00
  Other Income              :      -5,244,912.00
  Eearning Before Tax       :      12,036,525.00
  Tax                       :       1,058,207.00
  Net Income                :      10,978,318.00
  Closing Price             :          10,500.00

Per Share Data (Rp)
  Eps                       :          22,589.13
  Book Value                :          82,685.35

Financial Ratios
  Debt Equity Ratio (X)     :                .93
  Roa (%)                   :              14.13
  Roe (%)                   :              27.32
  Npm (%)                   :               7.58
  Opm (%)                   :              11.94

Cash Flow
  CF from Operating Activities                        :      22,453,444.00
  CF from Investing Activities                        :      -1,733,677.00
  CF from Financing Activities                        :               0.00
  Net Increase in Cash & Cash Equivalent              :      20,719,767.00
  Cash & Cash Equivalent at The Beginning of The Year :      10,280,876.00
  Cash & Cash Equivalent at The End of The Year       :      31,000,643.00

 
 
 
